Author:
Roufosse Florence E.,Kahn Jean-Emmanuel,Gleich Gerald J.,Schwartz Lawrence B.,Singh Anish D.,Rosenwasser Lanny J.,Denburg Judah A.,Ring Johannes,Rothenberg Marc E.,Sheikh Javed,Haig Ann E.,Mallett Stephen A.,Templeton Deborah N.,Ortega Hector G.,Klion Amy D.
Subject
Immunology,Immunology and Allergy
Reference14 articles.
1. Contemporary consensus proposal on criteria and classification of eosinophil disorders and related syndromes;Valent;J Allergy Clin Immunol,2012
2. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy;Ogbogu;J Allergy Clin Immunol,2009
3. Treatment of patients with the hypereosinophilic syndrome with mepolizumab;Rothenberg;N Engl J Med,2008
4. Howlander N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, et al. (eds). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER Web site, April 2012.
5. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis;Gevaert;J Allergy Clin Immunol,2011
Cited by
155 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献